• Remote neurology education, tirzepatide for obesity-related OSA, artificial intelligence for glioma assessment

  • Feb 6 2025
  • Duração: 5 minutos
  • Podcast

Remote neurology education, tirzepatide for obesity-related OSA, artificial intelligence for glioma assessment

  • Sumário

  • In this week’s podcast, Neurology Today’s editor-in-chief highlights articles on the pros and cons of virtual neurology education, the FDA approval of tirzepatide for obesity-related obstructive sleep apnea, and the promise of AI for glioma assessment.

    Exibir mais Exibir menos
activate_buybox_copy_target_t1

O que os ouvintes dizem sobre Remote neurology education, tirzepatide for obesity-related OSA, artificial intelligence for glioma assessment

Nota média dos ouvintes. Apenas ouvintes que tiverem escutado o título podem escrever avaliações.

Avaliações - Selecione as abas abaixo para mudar a fonte das avaliações.